| PERIOD ENDING | 3-Jan-10 | 4-Oct-09 | 5-Jul-09 | 31-Mar-09 | | Total Revenue | 1,141,529 | 1,207,964 | 1,209,134 | 1,256,958 | | Cost of Revenue | 891,148 | 962,262 | 949,289 | 970,133 | | | Gross Profit | 250,381 | 245,702 | 259,845 | 286,825 | | | Operating Expenses | | Research Development | 16,057 | 15,886 | 15,378 | 18,284 | | Selling General and Administrative | 97,924 | 94,942 | 113,095 | 123,845 | | Non Recurring |
-
|
-
|
-
| 108,500 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 136,400 | 134,874 | 131,372 | 36,196 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 164 | 124 | 86 | 164 | | Earnings Before Interest And Taxes | 136,564 | 134,998 | 131,458 | 36,360 | | Interest Expense | 17,918 | 19,361 | 20,935 | 14,315 | | Income Before Tax | 118,646 | 115,637 | 110,523 | 22,045 | | Income Tax Expense | 40,245 | 43,020 | 41,040 | 54,655 | | Minority Interest | (30) | (107) | (52) | (142) | | | | Net Income From Continuing Ops | 78,371 | 72,510 | 69,431 | (32,752) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 78,371 | 72,510 | 69,431 | (32,752) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $78,371 | $72,510 | $69,431 | ($32,752) |
|
0.41% Nasdaq 
Income Statement
